INFI
Infinity Pharmaceuticals, Inc.
INFI
INFI
Delisted
INFI was delisted on the 13th of September, 2023.
65 hedge funds and large institutions have $52.2M invested in Infinity Pharmaceuticals, Inc. in 2017 Q4 according to their latest regulatory filings, with 14 funds opening new positions, 11 increasing their positions, 27 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
65
Holders Change
+2
Holders Change %
+3.17%
% of All Funds
1.48%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
14
Increased
11
Reduced
27
Closed
12
Calls
$300K
Puts
$84K
Net Calls
+$216K
Net Calls Change
+$271K
Top Buyers
1 |
![]()
Fidelity Investments
Boston,
Massachusetts
|
+$7.28M |
2 |
BI
BVF Inc
San Francisco,
California
|
+$3.86M |
3 |
MWNA
Marshall Wace North America
New York
|
+$2.38M |
4 |
Millennium Management
New York
|
+$1.25M |
5 |
Dimensional Fund Advisors
Austin,
Texas
|
+$661K |
Top Sellers
1 |
Wellington Management Group
Boston,
Massachusetts
|
-$8.97M |
2 |
O
OrbiMed
New York
|
-$2.94M |
3 |
Renaissance Technologies
New York
|
-$1.81M |
4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$922K |
5 |
D.E. Shaw & Co
New York
|
-$561K |